Stay updated with breaking news from Dylan Sarver. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scientists at Johns Hopkins Medicine say that an experimental monoclonal antibody drug called mAb43 appears to prevent and reverse the onset of clinical type 1
Scientists at Johns Hopkins Medicine say that an experimental monoclonal antibody drug called mAb43 appears to prevent and reverse the onset of clinical type 1
DISCUSSION: Christian Science Discussion Group meets at 4 p.m. Wednesday, March 9, at Cabell County Public Library. Hymns, readings and a discussion of what Christian Science is will be offered.
Researchers at Johns Hopkins Medicine have found that a drug first developed to treat Alzheimer's disease, schizophrenia and sickle cell disease reduces obesity and fatty liver in mice and improves their heart function — without changes in food intake or daily activity.
After being placed on high-fat diets, mice were either selected to take the PDE9 inhibiting oral drug or a placebo. The PDE9 inhibitor reduced total